Cellular immune responses to HIV

Nature

Volumn 410, Issue 6831, 2001, Pages 980-987

  McMichael, A J ^a   Rowland Jones, S L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASE CONTROL; IMMUNOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS (HIV);

VIRUSES;

CD4 ANTIGEN; CD8 ANTIGEN;

CELL FUNCTION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFECTION CONTROL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HIV; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035912222     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35073658     Document Type: Review

References (110)

1. HIV-specific cytotoxic T lymphocytes in seropositive individuals
2. AIDS virus specific cytotoxic T lymphocytes in lung disorders
3. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma viral RNA load
4. + lymphocytes
5. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
6. + cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms
7. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
8. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
9. +04 disadvantage
10. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
11. Principles for adoptive T cell therapy of human viral diseases
12. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
13. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
14. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection
15. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys
16. + T cells in acute infectious mononucleosis
17. CD8(+) T-cell selection, function, and death in the primary immune response in vivo
18. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
19. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
20. + T cells with a predominant Vb usage during the primary immune response to HIV
21. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
22. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals
23. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys
24. Programmed death of T cells in HIV-1 infection
25. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
26. + T cells from HIV-infected persons
27. + T cells in individuals receiving highly active antiretroviral therapy (HAART)
28. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
29. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
30. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific
31. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant
32. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors
33. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
34. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection
35. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals
36. + T cells specific for EBV in healthy virus carriers
37. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
38. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
39. + T cell population
40. Functionality inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children
41. Cytotoxity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
42. Intracellural inactivation of the hepatitis B virus by cytotoxic T lymphocytes
43. Viral clearance without destruction of infected cells during acute HBV infection
44. A case for cytokines as effector molecules in the resolution of virus infections
45. Cytotoxic CD8+ T lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitope
46. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens
47. Mechanisms for the inhibition of HIV replication by interferons-α, -β, and -γ in primary human macrophages
48. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat
49. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: Effects on viral replication
50. Induction of HIV-1 replication in a chronically infected T-cell line by cytotoxic T lymphocytes
51. β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
52. Antigen-specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes
53. + T cells
54. CD8+ cell anti-HIV activity: Nonlytic suppression of virus replication
55. Controlling HIV pathogenesis: The role of noncytotoxic anti-HIV response of CD8+ T cells
56. Suppression of activation of the HIV LTR by CD8+ cells is not lentivirus specific
57. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes
58. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
59. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection
60. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway
61. Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells
62. Viral immune evasion due to persistence of activated T cells without effector function
63. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
64. + T-cells produce antiviral cytokines but are impaired in cytolytic function
65. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection
66. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3ζ, the signaling chain of the T-cell receptor complex
67. + T cells
68. Skewed maturation of memory HIV-1 specific CD8 T lymphocytes
69. + cell numbers and clinical staging
70. + T-cell responses associated with control of viremia
71. + T lymphocytes
72. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
73. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
74. + T cells
75. Immune control of HIV-1 after early treatment of acute infection
76. + T-helper and a T-killer cell
77. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
78. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
79. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome
80. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
81. Memory CD8+ T cells in HIV infection
82. Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
83. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
84. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
85. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
86. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted CTL responses
87. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab
88. The molecular basis of HIV capsid assembly
89. Functional consequences of mutations in HIV-1 Gag p55 selected by CTL pressure
90. +0201 are influenced by epitope mutation
91. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
92. Antigenic oscillations and shifting immunodominance in HIV-1 infections
93. The puzzle of HIV-1 subtypes in Africa
94. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules
95. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
96. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
97. Evasion of CTL responses by nef-dependent induction of Fas ligand expression on SIV-infected cells
98. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor ζ chain
99. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
100. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys
101. Modifications of CD8+ T cell function during in vivo memory, or tolerance induction
102. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
103. + nef-specific cytotoxic T cells in vaccinated macaques
104. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
105. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
106. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission
107. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
108. Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine